Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
40
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bloomer Aaron | EVP, Chief Financial Officer | 19 | $0 | $0 | 2026-03-23 |
| Herriott James | SVP, General Counsel & Sec | 85 | $0 | $967.9K | 2026-03-23 |
| Baranick Brian | Gen. Mgr., Precision Oncology | 80 | $0 | $1.18M | 2026-03-23 |
| Barber Michael J | Director | 7 | $0 | $0 | 2026-03-23 |
| Condella Sarah | SVP, Human Resources | 139 | $0 | $5.83M | 2026-03-23 |
| Petrovic Shacey | Director | 11 | $0 | $0 | 2026-03-23 |
| Doyle James Edward | Director | 38 | $32.1K | $2.75M | 2026-03-23 |
| Clancy Paul J | Director | 9 | $0 | $0 | 2026-03-23 |
| Zanotti Katherine S | Director | 53 | $80.9K | $10.06M | 2026-03-23 |
| Popovits Kimberly J | Director | 4 | $0 | $0 | 2026-03-23 |
| Conroy Kevin T | President and CEO | 369 | $1.27M | $171.86M | 2026-03-23 |
| Trigg Leslie | Director | 4 | $0 | $0 | 2026-03-23 |
| ORVILLE JACOB A | General Manager, Screening | 104 | $0 | $3.29M | 2026-03-23 |
| COWARD D SCOTT | SVP and General Counsel | 167 | $0 | $26.43M | 2026-03-23 |
| LEVANGIE DANIEL J | Director | 36 | $0 | $6.23M | 2025-06-12 |
| Sebelius Kathleen | Director | 9 | $0 | $0 | 2024-06-13 |
| Elliott Jeffrey Thomas | Chief Financial Officer | 144 | $0 | $30.97M | 2024-05-01 |
| Cunningham Everett | Chief Commercial Officer | 29 | $0 | $2.06M | 2024-05-01 |
| Scannell Timothy J | Director | 1 | $0 | $0 | 2023-10-31 |
| Jacquet Pierre | Director | 7 | $0 | $0 | 2023-06-08 |
| Lewis-Hall Freda C | Director | 5 | $0 | $0 | 2023-06-08 |
| LIDGARD GRAHAM PETER | Sr. VP, Chief Science Officer | 214 | $0 | $50.95M | 2021-03-11 |
| WYZGA MICHAEL S | Director | 19 | $0 | $3.68M | 2021-02-26 |
| Carey Thomas D. | Director | 25 | $94.3K | $7.15M | 2020-10-22 |
| Hoof Torsten | General Manager, International | 13 | $0 | $1.03M | 2020-09-24 |
| Casdin Eli | Director | 6 | $0 | $0 | 2020-07-23 |
| Slavitt Andrew M | Director | 3 | $0 | $0 | 2020-07-23 |
| Paulsen Gisela | Gen Mgr, Precision Oncology | 1 | $0 | $0 | 2020-04-20 |
| Stenhouse Mark | President, Cologuard | 14 | $0 | $1.80M | 2020-04-03 |
| Cole G Bradley | General Manager - Diagnostics | 9 | $0 | $5.89M | 2020-02-19 |
| Johnson Scott C. | SVP - Research and Development | 10 | $0 | $491.8K | 2019-09-12 |
| Fallon John A. | Director | 5 | $0 | $139.7K | 2018-07-30 |
| THOMPSON DAVID | Director | 21 | $406.4K | $0 | 2018-07-26 |
| ARORA MANEESH | Senior VP and CFO | 122 | $9.0K | $18.01M | 2018-03-12 |
| Sterling Lionel | Director | 9 | $140.4K | $0 | 2017-07-27 |
| BAKEWELL JOHN K | Chief Financial Officer | 2 | $0 | $0 | 2016-01-01 |
| Megan William J. | SVP, Finance & PFO | 12 | $117.9K | $0 | 2015-08-26 |
| CRAWFORD SALLY | Director | 34 | $0 | $2.26M | 2014-10-20 |
| Connelly James P | Director | 7 | $0 | $0 | 2013-08-27 |
| Stoltenberg Laura S | Chief Commercial Officer | 6 | $0 | $0 | 2013-03-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Barber Michael J | Director | D To issuer deriv | 2026-03-23 | 2026-03-23 | 7,422 | — | $0 | 0 | SEC↗ |
| COWARD D SCOTT | Director | D To issuer deriv | 2026-03-23 | 2026-03-23 | 10,786 | — | $0 | 0 | SEC↗ |
| COWARD D SCOTT | Director | D To issuer deriv | 2026-03-23 | 2026-03-23 | 12,875 | — | $0 | 0 | SEC↗ |
| COWARD D SCOTT | Director | D To issuer deriv | 2026-03-23 | 2026-03-23 | 4,175 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | D To issuer deriv | 2026-03-23 | 2026-03-23 | 6,581 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | D To issuer deriv | 2026-03-23 | 2026-03-23 | 38,707 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 235,388 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 66,047 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 34,110 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 100,916 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 83,360 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 44,336 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 18,143 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer deriv | 2026-03-23 | 2026-03-23 | 154,829 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | D To issuer deriv | 2026-03-23 | 2026-03-23 | 21,948 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | D To issuer deriv | 2026-03-23 | 2026-03-23 | 11,700 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | D To issuer deriv | 2026-03-23 | 2026-03-23 | 7,790 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | D To issuer deriv | 2026-03-23 | 2026-03-23 | 23,224 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | D To issuer deriv | 2026-03-23 | 2026-03-23 | 6,581 | — | $0 | 0 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | D To issuer deriv | 2026-03-23 | 2026-03-23 | 28,063 | — | $0 | 0 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | D To issuer deriv | 2026-03-23 | 2026-03-23 | 4,395 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | D To issuer deriv | 2026-03-23 | 2026-03-23 | 20,321 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | D To issuer deriv | 2026-03-23 | 2026-03-23 | 2,861 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | D To issuer deriv | 2026-03-23 | 2026-03-23 | 793 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | D To issuer deriv | 2026-03-23 | 2026-03-23 | 28,063 | — | $0 | 0 | SEC↗ |
| Trigg Leslie | Director | D To issuer | 2026-03-23 | 2026-03-23 | 13,925 | — | $0 | 0 | SEC↗ |
| Trigg Leslie | Director | D To issuer | 2026-03-23 | 2026-03-23 | 3,244 | — | $0 | 13,925 | SEC↗ |
| Barber Michael J | Director | D To issuer | 2026-03-23 | 2026-03-23 | 5,398 | — | $0 | 0 | SEC↗ |
| Barber Michael J | Director | D To issuer | 2026-03-23 | 2026-03-23 | 7,738 | — | $0 | 5,398 | SEC↗ |
| Clancy Paul J | Director | D To issuer | 2026-03-23 | 2026-03-23 | 5,398 | — | $0 | 0 | SEC↗ |
| Clancy Paul J | Director | D To issuer | 2026-03-23 | 2026-03-23 | 20,640 | — | $0 | 5,398 | SEC↗ |
| Doyle James Edward | Director | D To issuer | 2026-03-23 | 2026-03-23 | 5,398 | — | $0 | 0 | SEC↗ |
| Doyle James Edward | Director | D To issuer | 2026-03-23 | 2026-03-23 | 52,564 | — | $0 | 5,398 | SEC↗ |
| Popovits Kimberly J | Director | D To issuer | 2026-03-23 | 2026-03-23 | 6,725 | — | $0 | 9,656 | SEC↗ |
| Popovits Kimberly J | Director | D To issuer | 2026-03-23 | 2026-03-23 | 9,656 | — | $0 | 0 | SEC↗ |
| Zanotti Katherine S | Director | D To issuer | 2026-03-23 | 2026-03-23 | 5,398 | — | $0 | 0 | SEC↗ |
| Zanotti Katherine S | Director | D To issuer | 2026-03-23 | 2026-03-23 | 55,361 | — | $0 | 5,398 | SEC↗ |
| Petrovic Shacey | Director | D To issuer | 2026-03-23 | 2026-03-23 | 16,406 | — | $0 | 5,398 | SEC↗ |
| Petrovic Shacey | Director | D To issuer | 2026-03-23 | 2026-03-23 | 7,095 | — | $0 | 0 | SEC↗ |
| Petrovic Shacey | Director | D To issuer | 2026-03-23 | 2026-03-23 | 5,398 | — | $0 | 0 | SEC↗ |
| COWARD D SCOTT | Director | D To issuer | 2026-03-23 | 2026-03-23 | 5,398 | — | $0 | 0 | SEC↗ |
| COWARD D SCOTT | Director | D To issuer | 2026-03-23 | 2026-03-23 | 4,694 | — | $0 | 0 | SEC↗ |
| COWARD D SCOTT | Director | D To issuer | 2026-03-23 | 2026-03-23 | 52,164 | — | $0 | 5,398 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | D To issuer | 2026-03-23 | 2026-03-23 | 1,774 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | D To issuer | 2026-03-23 | 2026-03-23 | 153,726 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award | 2026-03-23 | 2026-03-23 | 53,323 | — | $0 | 153,726 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer | 2026-03-23 | 2026-03-23 | 117,427 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award | 2026-03-23 | 2026-03-23 | 119,312 | — | $0 | 1,397,738 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer | 2026-03-23 | 2026-03-23 | 1,397,738 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer | 2026-03-23 | 2026-03-23 | 46,538 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer | 2026-03-23 | 2026-03-23 | 86,750 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | D To issuer | 2026-03-23 | 2026-03-23 | 29,061 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | D To issuer | 2026-03-23 | 2026-03-23 | 6,368 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | A Award | 2026-03-23 | 2026-03-23 | 60,389 | — | $0 | 191,891 | SEC↗ |
| Condella Sarah | EVP, Human Resources | D To issuer | 2026-03-23 | 2026-03-23 | 191,891 | — | $0 | 0 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | D To issuer | 2026-03-23 | 2026-03-23 | 138,679 | — | $0 | 0 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | D To issuer | 2026-03-23 | 2026-03-23 | 417 | — | $0 | 0 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | A Award | 2026-03-23 | 2026-03-23 | 89,911 | — | $0 | 138,679 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | D To issuer | 2026-03-23 | 2026-03-23 | 1,762 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | D To issuer | 2026-03-23 | 2026-03-23 | 68,195 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | D To issuer | 2026-03-23 | 2026-03-23 | 137,195 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | D To issuer | 2026-03-23 | 2026-03-23 | 795 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award | 2026-03-23 | 2026-03-23 | 33,321 | — | $0 | 137,195 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2026-02-27 | 2026-03-03 | 3,900 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2026-02-27 | 2026-03-03 | 18,143 | — | $0 | 18,143 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2026-02-27 | 2026-03-03 | 22,168 | — | $0 | 44,336 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2026-02-27 | 2026-03-03 | 27,786 | — | $0 | 83,360 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2026-02-27 | 2026-03-03 | 3,900 | $5.03 | $19.6K | 133,034 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2026-02-27 | 2026-03-03 | 1,913 | $103.38 | $197.8K | 131,121 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2026-02-27 | 2026-03-03 | 13,060 | $103.25 | $1.35M | 1,278,045 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2026-02-27 | 2026-03-03 | 18,143 | — | $0 | 1,260,098 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2026-02-27 | 2026-03-03 | 27,786 | — | $0 | 1,291,105 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2026-02-27 | 2026-03-03 | 10,419 | $103.25 | $1.08M | 1,263,319 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2026-02-27 | 2026-03-03 | 22,168 | — | $0 | 1,273,738 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2026-02-27 | 2026-03-03 | 8,528 | $103.25 | $880.5K | 1,251,570 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award deriv | 2026-02-25 | 2026-02-27 | 154,829 | — | $0 | 154,829 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award deriv | 2026-02-25 | 2026-02-27 | 20,321 | — | $0 | 20,321 | SEC↗ |
| Condella Sarah | EVP, Human Resources | A Award deriv | 2026-02-25 | 2026-02-27 | 23,224 | — | $0 | 23,224 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | A Award deriv | 2026-02-25 | 2026-02-27 | 28,063 | — | $0 | 28,063 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award deriv | 2026-02-25 | 2026-02-27 | 28,063 | — | $0 | 28,063 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award deriv | 2026-02-25 | 2026-02-27 | 38,707 | — | $0 | 38,707 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2026-02-25 | 2026-02-27 | 6,196 | $103.45 | $641.0K | 1,241,955 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award | 2026-02-25 | 2026-02-27 | 13,181 | — | $0 | 1,248,151 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-24 | 2025-12-30 | 14,938 | $101.59 | $1.52M | 103,874 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award | 2025-12-24 | 2025-12-30 | 29,416 | — | $0 | 118,812 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise deriv | 2025-12-23 | 2025-12-30 | 24,384 | — | $0 | 4,395 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise deriv | 2025-12-23 | 2025-12-30 | 38,715 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-12-23 | 2025-12-30 | 7,125 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-12-23 | 2025-12-30 | 3,780 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-12-23 | 2025-12-30 | 7,334 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-12-23 | 2025-12-30 | 13,893 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-12-23 | 2025-12-30 | 1,648 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-12-23 | 2025-12-30 | 7,560 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-12-23 | 2025-12-30 | 3,955 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-12-23 | 2025-12-30 | 23,817 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-12-23 | 2025-12-30 | 11,876 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-12-23 | 2025-12-30 | 16,051 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-12-23 | 2025-12-30 | 14,845 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-12-23 | 2025-12-30 | 28,779 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-12-23 | 2025-12-30 | 9,450 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-12-23 | 2025-12-30 | 3,955 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-12-23 | 2025-12-30 | 9,450 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-12-23 | 2025-12-30 | 3,955 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-12-23 | 2025-12-30 | 14,845 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-12-23 | 2025-12-30 | 16,051 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-12-23 | 2025-12-30 | 28,779 | — | $0 | 0 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | F Tax w/h | 2025-12-23 | 2025-12-30 | 10,803 | $101.82 | $1.10M | 48,768 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise | 2025-12-23 | 2025-12-30 | 24,384 | — | $0 | 59,571 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | F Tax w/h | 2025-12-23 | 2025-12-30 | 17,151 | $101.82 | $1.75M | 35,187 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise | 2025-12-23 | 2025-12-30 | 38,715 | — | $0 | 52,338 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-12-23 | 2025-12-30 | 13,893 | — | $0 | 32,934 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 3,349 | $101.82 | $341.0K | 18,237 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-12-23 | 2025-12-30 | 7,125 | — | $0 | 21,586 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-12-23 | 2025-12-30 | 7,334 | — | $0 | 32,934 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-12-23 | 2025-12-30 | 1,648 | — | $0 | 13,233 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 775 | $101.82 | $78.9K | 12,458 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-12-23 | 2025-12-30 | 3,780 | — | $0 | 16,238 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 7,118 | $101.82 | $724.8K | 67,815 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award | 2025-12-23 | 2025-12-30 | 15,144 | — | $0 | 74,933 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 14,235 | $101.82 | $1.45M | 59,789 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award | 2025-12-23 | 2025-12-30 | 30,287 | — | $0 | 74,024 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 4,644 | $101.82 | $472.9K | 43,737 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award | 2025-12-23 | 2025-12-30 | 9,880 | — | $0 | 48,381 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 7,995 | $101.82 | $814.1K | 38,501 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award | 2025-12-23 | 2025-12-30 | 17,009 | — | $0 | 46,496 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 3,447 | $101.82 | $351.0K | 29,487 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 1,777 | $101.82 | $180.9K | 14,461 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-12-23 | 2025-12-30 | 6,530 | $101.82 | $664.9K | 25,600 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award | 2025-12-23 | 2025-12-30 | 244,931 | — | $0 | 1,101,519 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-12-23 | 2025-12-30 | 115,118 | $101.82 | $11.72M | 986,401 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-12-23 | 2025-12-30 | 65,014 | $101.82 | $6.62M | 1,059,713 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award | 2025-12-23 | 2025-12-30 | 138,326 | — | $0 | 1,124,727 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award | 2025-12-23 | 2025-12-30 | 330,674 | — | $0 | 155,417 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-12-23 | 2025-12-30 | 155,417 | $101.82 | $15.82M | 1,234,970 | SEC↗ |
| Condella Sarah | EVP, Human Resources | A Award | 2025-12-23 | 2025-12-30 | 8,000 | — | $0 | 132,894 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-12-23 | 2025-12-30 | 11,876 | — | $0 | 99,824 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-12-23 | 2025-12-30 | 3,554 | $101.82 | $361.9K | 87,948 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-12-23 | 2025-12-30 | 7,560 | — | $0 | 91,502 | SEC↗ |
| Condella Sarah | EVP, Human Resources | A Award | 2025-12-23 | 2025-12-30 | 34,018 | — | $0 | 140,883 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-12-23 | 2025-12-30 | 15,989 | $101.82 | $1.63M | 124,894 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-12-23 | 2025-12-30 | 11,194 | $101.82 | $1.14M | 106,865 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-12-23 | 2025-12-30 | 3,760 | $101.82 | $382.8K | 129,134 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-12-23 | 2025-12-30 | 1,859 | $101.82 | $189.3K | 83,942 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-12-23 | 2025-12-30 | 3,955 | — | $0 | 85,801 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-12-23 | 2025-12-30 | 23,817 | — | $0 | 118,059 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-12-23 | 2025-12-30 | 5,582 | $101.82 | $568.4K | 94,242 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-12-23 | 2025-12-30 | 3,955 | — | $0 | 26,323 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-23 | 2025-12-30 | 10,453 | $101.82 | $1.06M | 89,396 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award | 2025-12-23 | 2025-12-30 | 20,584 | — | $0 | 99,849 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-23 | 2025-12-30 | 21,594 | $101.82 | $2.20M | 79,265 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award | 2025-12-23 | 2025-12-30 | 42,523 | — | $0 | 100,859 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-23 | 2025-12-30 | 8,151 | $101.82 | $829.9K | 58,336 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-12-23 | 2025-12-30 | 16,051 | — | $0 | 66,487 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-23 | 2025-12-30 | 14,614 | $101.82 | $1.49M | 50,436 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-12-23 | 2025-12-30 | 28,779 | — | $0 | 65,050 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-23 | 2025-12-30 | 7,539 | $101.82 | $767.6K | 36,271 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-12-23 | 2025-12-30 | 14,845 | — | $0 | 43,810 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-23 | 2025-12-30 | 4,799 | $101.82 | $488.6K | 28,965 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-12-23 | 2025-12-30 | 9,450 | — | $0 | 33,764 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-12-23 | 2025-12-30 | 2,009 | $101.82 | $204.6K | 24,314 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-12-23 | 2025-12-30 | 28,779 | — | $0 | 66,987 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 6,978 | $101.82 | $710.5K | 38,208 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-12-23 | 2025-12-30 | 14,845 | — | $0 | 45,186 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 13,527 | $101.82 | $1.38M | 53,460 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-12-23 | 2025-12-30 | 16,051 | — | $0 | 69,511 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 7,544 | $101.82 | $768.1K | 61,967 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award | 2025-12-23 | 2025-12-30 | 42,523 | — | $0 | 104,490 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 19,986 | $101.82 | $2.03M | 84,504 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award | 2025-12-23 | 2025-12-30 | 20,584 | — | $0 | 105,088 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 9,675 | $101.82 | $985.1K | 95,413 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award | 2025-12-23 | 2025-12-30 | 9,416 | — | $0 | 104,829 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-12-23 | 2025-12-30 | 9,450 | — | $0 | 34,783 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 1,859 | $101.82 | $189.3K | 25,333 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-12-23 | 2025-12-30 | 3,955 | — | $0 | 27,192 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 4,442 | $101.82 | $452.3K | 30,341 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-12-23 | 2025-12-30 | 4,426 | $101.82 | $450.7K | 100,403 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | S Sale | 2025-11-19 | 2025-11-21 | 1,000 | $70.00 | $70.0K | 11,585 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | S Sale | 2025-11-19 | 2025-11-21 | 5,000 | $75.00 | $375.0K | 23,237 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | S Sale | 2025-11-04 | 2025-11-06 | 2,858 | $70.08 | $200.3K | 22,368 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | S Sale | 2025-11-04 | 2025-11-06 | 1,500 | $70.08 | $105.1K | 12,585 | SEC↗ |
| Zanotti Katherine S | Director | S Sale | 2025-10-24 | 2025-10-27 | 12,000 | $65.00 | $780.0K | 60,759 | SEC↗ |
| Doyle James Edward | Director | S Sale | 2025-10-09 | 2025-10-10 | 2,000 | $60.00 | $120.0K | 57,962 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | S Sale | 2025-10-09 | 2025-10-10 | 1,500 | $60.00 | $90.0K | 14,085 | SEC↗ |
| Doyle James Edward | Director | S Sale | 2025-08-13 | 2025-08-14 | 1,485 | $42.02 | $62.4K | 59,962 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-08-05 | 2025-08-07 | 5,350 | — | $0 | 16,051 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-08-05 | 2025-08-07 | 5,350 | — | $0 | 16,051 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-08-05 | 2025-08-07 | 2,717 | $46.83 | $127.2K | 25,226 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-08-05 | 2025-08-07 | 5,350 | — | $0 | 27,943 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-08-05 | 2025-08-07 | 2,515 | $46.83 | $117.8K | 28,237 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-08-05 | 2025-08-07 | 5,350 | — | $0 | 30,752 | SEC↗ |
| Zanotti Katherine S | Director | S Sale | 2025-06-13 | 2025-06-16 | 3,207 | $53.20 | $170.6K | 72,759 | SEC↗ |
| Zanotti Katherine S | Director | A Award | 2025-06-12 | 2025-06-16 | 5,398 | — | $0 | 75,966 | SEC↗ |
| COWARD D SCOTT | Director | A Award | 2025-06-12 | 2025-06-16 | 5,398 | — | $0 | 57,562 | SEC↗ |
| LEVANGIE DANIEL J | Director | A Award | 2025-06-12 | 2025-06-16 | 5,398 | — | $0 | 34,312 | SEC↗ |
| Petrovic Shacey | Director | A Award | 2025-06-12 | 2025-06-16 | 5,398 | — | $0 | 21,804 | SEC↗ |
| Trigg Leslie | Director | A Award | 2025-06-12 | 2025-06-16 | 7,670 | — | $0 | 17,169 | SEC↗ |
| Popovits Kimberly J | Director | A Award | 2025-06-12 | 2025-06-16 | 9,994 | — | $0 | 16,381 | SEC↗ |
| Clancy Paul J | Director | A Award | 2025-06-12 | 2025-06-16 | 5,398 | — | $0 | 26,038 | SEC↗ |
| Barber Michael J | Director | A Award | 2025-06-12 | 2025-06-16 | 7,197 | — | $0 | 13,136 | SEC↗ |
| Doyle James Edward | Director | A Award | 2025-06-12 | 2025-06-16 | 5,398 | — | $0 | 61,447 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award deriv | 2025-05-06 | 2025-05-08 | 7,334 | — | $0 | 7,334 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award | 2025-04-30 | 2025-05-08 | 363 | $38.26 | $13.9K | 15,585 | SEC↗ |
| Trigg Leslie | Director | A Award | 2025-04-29 | 2025-05-01 | 8,527 | — | $0 | 9,499 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise deriv | 2025-04-15 | 2025-04-17 | 11,566 | — | $0 | 0 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise deriv | 2025-04-15 | 2025-04-17 | 12,904 | — | $0 | 38,715 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise | 2025-04-15 | 2025-04-17 | 11,556 | — | $0 | 11,556 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | F Tax w/h | 2025-04-15 | 2025-04-17 | 5,120 | $44.25 | $226.6K | 6,436 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | M Exercise | 2025-04-15 | 2025-04-17 | 12,904 | — | $0 | 19,340 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | F Tax w/h | 2025-04-15 | 2025-04-17 | 5,717 | $44.25 | $253.0K | 13,623 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2025-03-07 | 2025-03-10 | 66,723 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2025-03-07 | 2025-03-10 | 66,723 | $22.38 | $1.49M | 1,203,269 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-03-07 | 2025-03-10 | 48,929 | $47.06 | $2.30M | 1,154,340 | SEC↗ |
| Condella Sarah | EVP, Human Resources | G Gift | 2025-03-03 | 2025-03-04 | 1,055 | — | $0 | 81,483 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-02-28 | 2025-03-04 | 3,958 | — | $0 | 11,876 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-02-28 | 2025-03-04 | 3,780 | — | $0 | 7,560 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-02-28 | 2025-03-04 | 4,948 | — | $0 | 14,845 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-02-28 | 2025-03-04 | 4,725 | — | $0 | 9,450 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-02-28 | 2025-03-04 | 4,725 | — | $0 | 9,450 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-02-28 | 2025-03-04 | 4,948 | — | $0 | 14,845 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2025-02-28 | 2025-03-04 | 22,167 | — | $0 | 66,504 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2025-02-28 | 2025-03-04 | 18,143 | — | $0 | 36,286 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-02-28 | 2025-03-04 | 2,375 | — | $0 | 7,125 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-02-28 | 2025-03-04 | 1,890 | — | $0 | 3,780 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-02-28 | 2025-03-04 | 1,861 | $47.82 | $89.0K | 82,538 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-02-28 | 2025-03-04 | 3,958 | — | $0 | 84,399 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-02-28 | 2025-03-04 | 3,780 | — | $0 | 82,218 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-02-28 | 2025-03-04 | 1,777 | $47.82 | $85.0K | 80,441 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-02-28 | 2025-03-04 | 2,326 | $47.82 | $111.2K | 25,402 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-02-28 | 2025-03-04 | 4,725 | — | $0 | 25,001 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-02-28 | 2025-03-04 | 2,221 | $47.82 | $106.2K | 22,780 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-02-28 | 2025-03-04 | 4,948 | — | $0 | 27,728 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-02-28 | 2025-03-04 | 2,513 | $47.82 | $120.2K | 22,593 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-02-28 | 2025-03-04 | 4,948 | — | $0 | 25,106 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-02-28 | 2025-03-04 | 2,400 | $47.82 | $114.8K | 20,158 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-02-28 | 2025-03-04 | 4,725 | — | $0 | 22,558 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2025-02-28 | 2025-03-04 | 18,143 | — | $0 | 1,133,326 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-02-28 | 2025-03-04 | 8,528 | $47.82 | $407.8K | 1,124,798 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-02-28 | 2025-03-04 | 10,419 | $47.82 | $498.2K | 1,136,546 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2025-02-28 | 2025-03-04 | 22,167 | — | $0 | 1,146,965 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-02-28 | 2025-03-04 | 889 | $47.82 | $42.5K | 13,964 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-02-28 | 2025-03-04 | 1,117 | $47.82 | $53.4K | 15,222 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-02-28 | 2025-03-04 | 2,375 | — | $0 | 16,339 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-02-28 | 2025-03-04 | 1,890 | — | $0 | 14,853 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2025-02-25 | 2025-02-26 | 13,180 | — | $0 | 13,181 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-02-25 | 2025-02-26 | 3,954 | — | $0 | 3,955 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-02-25 | 2025-02-26 | 1,647 | — | $0 | 1,648 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-02-25 | 2025-02-26 | 3,954 | — | $0 | 3,955 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-02-25 | 2025-02-26 | 3,954 | — | $0 | 3,955 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2025-02-25 | 2025-02-26 | 13,180 | — | $0 | 1,121,378 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-02-25 | 2025-02-26 | 6,195 | $51.28 | $317.7K | 1,115,183 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-02-25 | 2025-02-26 | 3,954 | — | $0 | 22,136 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-02-25 | 2025-02-26 | 1,859 | $51.28 | $95.3K | 20,277 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-02-25 | 2025-02-26 | 1,647 | — | $0 | 13,738 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-02-25 | 2025-02-26 | 775 | $51.28 | $39.7K | 12,963 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-02-25 | 2025-02-26 | 2,008 | $51.28 | $103.0K | 17,833 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-02-25 | 2025-02-26 | 3,954 | — | $0 | 19,841 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-02-25 | 2025-02-26 | 1,859 | $51.28 | $95.3K | 78,438 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-02-25 | 2025-02-26 | 3,954 | — | $0 | 80,297 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award deriv | 2025-02-24 | 2025-02-26 | 111,146 | — | $0 | 111,146 | SEC↗ |
| Bloomer Aaron | EVP, Chief Financial Officer | A Award deriv | 2025-02-24 | 2025-02-26 | 28,779 | — | $0 | 28,779 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award deriv | 2025-02-24 | 2025-02-26 | 28,779 | — | $0 | 28,779 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award deriv | 2025-02-24 | 2025-02-26 | 13,893 | — | $0 | 13,893 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award deriv | 2025-02-24 | 2025-02-26 | 28,779 | — | $0 | 28,779 | SEC↗ |
| Condella Sarah | EVP, Human Resources | A Award deriv | 2025-02-24 | 2025-02-26 | 23,817 | — | $0 | 23,817 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | A Award | 2025-02-20 | 2025-02-21 | 3,324 | — | $0 | 13,622 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-02-20 | 2025-02-21 | 1,531 | $50.48 | $77.3K | 12,091 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award | 2025-02-20 | 2025-02-21 | 4,805 | — | $0 | 20,407 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-02-20 | 2025-02-21 | 2,225 | $50.48 | $112.3K | 18,182 | SEC↗ |
| Conroy Kevin T | President and CEO | A Award | 2025-02-20 | 2025-02-21 | 48,044 | — | $0 | 1,129,338 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-02-20 | 2025-02-21 | 21,140 | $50.48 | $1.07M | 1,108,198 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-02-20 | 2025-02-21 | 2,214 | $50.48 | $111.8K | 76,343 | SEC↗ |
| Condella Sarah | EVP, Human Resources | A Award | 2025-02-20 | 2025-02-21 | 4,805 | — | $0 | 78,557 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award | 2025-02-20 | 2025-02-21 | 4,805 | — | $0 | 18,324 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-02-20 | 2025-02-21 | 2,437 | $50.48 | $123.0K | 15,887 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise deriv | 2025-02-19 | 2025-02-21 | 865 | — | $0 | 0 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise deriv | 2025-02-19 | 2025-02-21 | 2,248 | — | $0 | 0 | SEC↗ |
| COWARD D SCOTT | Director | M Exercise deriv | 2025-02-19 | 2025-02-21 | 2,248 | — | $0 | 0 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise deriv | 2025-02-19 | 2025-02-21 | 10,374 | — | $0 | 0 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise deriv | 2025-02-19 | 2025-02-21 | 2,248 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2025-02-19 | 2025-02-21 | 1,729 | — | $0 | 0 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | F Tax w/h | 2025-02-19 | 2025-02-21 | 433 | $49.63 | $21.5K | 10,298 | SEC↗ |
| Herriott James | SVP, General Counsel & Sec | M Exercise | 2025-02-19 | 2025-02-21 | 865 | — | $0 | 10,731 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | M Exercise | 2025-02-19 | 2025-02-21 | 2,248 | — | $0 | 16,688 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | F Tax w/h | 2025-02-19 | 2025-02-21 | 1,086 | $49.63 | $53.9K | 15,602 | SEC↗ |
| COWARD D SCOTT | Director | M Exercise | 2025-02-19 | 2025-02-21 | 2,248 | — | $0 | 52,831 | SEC↗ |
| COWARD D SCOTT | Director | F Tax w/h | 2025-02-19 | 2025-02-21 | 667 | $49.63 | $33.1K | 52,164 | SEC↗ |
| Conroy Kevin T | President and CEO | F Tax w/h | 2025-02-19 | 2025-02-21 | 3,271 | $49.63 | $162.3K | 1,081,294 | SEC↗ |
| Conroy Kevin T | President and CEO | M Exercise | 2025-02-19 | 2025-02-21 | 10,374 | — | $0 | 1,084,565 | SEC↗ |
| Condella Sarah | EVP, Human Resources | F Tax w/h | 2025-02-19 | 2025-02-21 | 1,107 | $49.63 | $54.9K | 73,752 | SEC↗ |
| Condella Sarah | EVP, Human Resources | M Exercise | 2025-02-19 | 2025-02-21 | 2,248 | — | $0 | 74,859 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2025-02-19 | 2025-02-21 | 968 | $49.63 | $48.0K | 13,519 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise | 2025-02-19 | 2025-02-21 | 1,729 | — | $0 | 14,487 | SEC↗ |
| Popovits Kimberly J | Director | A Award | 2025-01-02 | 2025-01-06 | 6,387 | — | $0 | 6,387 | SEC↗ |
| Conroy Kevin T | President and CEO | P Buy | 2024-11-13 | 2024-11-13 | 19,500 | $51.35 | $1.00M | 1,074,191 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | S Sale | 2024-10-08 | 2024-10-09 | 929 | $70.00 | $65.0K | 12,758 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | S Sale | 2024-09-18 | 2024-09-19 | 929 | $70.00 | $65.0K | 13,687 | SEC↗ |
| ORVILLE JACOB A | EVP, GM, Screening | A Award deriv | 2024-08-05 | 2024-08-06 | 21,401 | — | $0 | 21,401 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | A Award deriv | 2024-08-05 | 2024-08-06 | 21,401 | — | $0 | 21,401 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | M Exercise deriv | 2024-08-05 | 2024-08-06 | 2,712 | — | $0 | 0 | SEC↗ |
| Baranick Brian | EVP, GM, Precision Oncology | F Tax w/h | 2024-08-05 | 2024-08-06 | 1,375 | $55.77 | $76.7K | 14,616 | SEC↗ |